Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for COVID-19 Anosmia
NCT04495816Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anosmia (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Brief Smell Identification Test at 6 weeks. Started Jul 2020; status: completed.
02
Conditions
anosmia
Beyond the preview
Go deeper on NCT04495816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495816.